An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

Completed · Phase 2

Conditions studied: Depressive Disorder, Major

In brief

A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Medication in Patients with Major Depressive Disorder (MDD)

Key facts

Study ID

NCT00057226

Run by

GlaxoSmithKline

People needed

365

Starts

2003-03-01

Expected to finish

2004-04-01

Last updated by the study team

2015-04-16

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Major Depressive Disorder (MDD)
• Duration of current depressive episode 12 weeks - 24 months
• Patients can read and write at a level sufficient to provide a signed consent
• If female, patients must be practicing an acceptable method of birth control

You may not qualify if…

• Patients have other psychiatric disorders that would affect patient's response to treatment
• Patients have not responded to two or more adequate courses of antidepressant therapy
• Patients cannot be currently abusing illicit drugs or alcohol
• Patients are not currently receiving psychotherapy
• Patients have received electroconvulsive therapy within 6 months prior to screening
• Patients are pregnant or lactating

Where it is running

• GSK Investigational Site — Cerritos, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Washington D.C., District of Columbia, United States
• GSK Investigational Site — Boynton Beach, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Marietta, Georgia, United States
• GSK Investigational Site — Libertyville, Illinois, United States
• GSK Investigational Site — Oakbrook Terrace, Illinois, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Lafayette, Indiana, United States
• GSK Investigational Site — Shreveport, Louisiana, United States
• GSK Investigational Site — Rockville, Maryland, United States
• GSK Investigational Site — Saint Charles, Missouri, United States
• GSK Investigational Site — Albuquerque, New Mexico, United States
• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Toledo, Ohio, United States
• GSK Investigational Site — Memphis, Tennessee, United States
• GSK Investigational Site — Nashville, Tennessee, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Bellevue, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.